0001739614-23-000014.txt : 20230301 0001739614-23-000014.hdr.sgml : 20230301 20230301164137 ACCESSION NUMBER: 0001739614-23-000014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230228 FILED AS OF DATE: 20230301 DATE AS OF CHANGE: 20230301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lappe Mark CENTRAL INDEX KEY: 0001366074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39452 FILM NUMBER: 23694318 MAIL ADDRESS: STREET 1: 11622 EL CAMINO REAL STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lappe Family Trust CENTRAL INDEX KEY: 0001821266 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39452 FILM NUMBER: 23694317 BUSINESS ADDRESS: STREET 1: C/O INHIBRX, INC. STREET 2: 11099 TORREY PINES ROAD, SUITE 280 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-759-1499 MAIL ADDRESS: STREET 1: C/O INHIBRX, INC. STREET 2: 11099 TORREY PINES ROAD, SUITE 280 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibrx, Inc. CENTRAL INDEX KEY: 0001739614 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 824257312 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 795-4220 MAIL ADDRESS: STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 wf-form4_167770687699240.xml FORM 4 X0306 4 2023-02-28 0 0001739614 Inhibrx, Inc. INBX 0001366074 Lappe Mark C/O INHIBRX, INC. 11025 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 1 1 0 0 Chief Executive Officer 0001821266 Lappe Family Trust C/O INHIBRX, INC. 11025 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 0 0 0 1 To be Verified Common Stock 2023-02-28 4 S 0 60 25.0208 D 2486192 I By the Lappe Family Trust Common Stock 500000 I By trust Common Stock 59462 I The Mark Paul Lappe Roth IRA The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mark P. Lappe. The shares were sold in multiple transactions at prices ranging from $25.005 to $25.07, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. These securities are directly owned by the Lappe Family Trust. Mark P. Lappe is a trustee of the Lappe Family Trust and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Lappe Family Trust. These securities are directly owned by a trust, for the benefit of the reporting person's immediate family. Mark P. Lappe, as an immediate family member of the beneficiaries of the trust, may be deemed to indirectly beneficially own the securities owned by the trust. /s/ Kelly D. Deck, attorney-in-fact 2023-03-01